DE60128218D1 - METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR - Google Patents

METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR

Info

Publication number
DE60128218D1
DE60128218D1 DE60128218T DE60128218T DE60128218D1 DE 60128218 D1 DE60128218 D1 DE 60128218D1 DE 60128218 T DE60128218 T DE 60128218T DE 60128218 T DE60128218 T DE 60128218T DE 60128218 D1 DE60128218 D1 DE 60128218D1
Authority
DE
Germany
Prior art keywords
galnac
lectin domains
transferases
functions
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128218T
Other languages
English (en)
Inventor
Henrik Clausen
Helle Hassan
Celso Albuquerque Reis
Eric Paul Bennett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlycoZym ApS
Original Assignee
GlycoZym ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlycoZym ApS filed Critical GlycoZym ApS
Application granted granted Critical
Publication of DE60128218D1 publication Critical patent/DE60128218D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/005Enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91097Hexosyltransferases (general) (2.4.1)
    • G01N2333/91102Hexosyltransferases (general) (2.4.1) with definite EC number (2.4.1.-)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
DE60128218T 2000-05-11 2001-05-10 METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR Expired - Lifetime DE60128218D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20333100P 2000-05-11 2000-05-11
PCT/DK2001/000328 WO2001085215A2 (en) 2000-05-11 2001-05-10 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS

Publications (1)

Publication Number Publication Date
DE60128218D1 true DE60128218D1 (de) 2007-06-14

Family

ID=22753535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128218T Expired - Lifetime DE60128218D1 (de) 2000-05-11 2001-05-10 METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR

Country Status (5)

Country Link
EP (1) EP1282725B1 (de)
AT (1) ATE361375T1 (de)
AU (1) AU2001258234A1 (de)
DE (1) DE60128218D1 (de)
WO (1) WO2001085215A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338932B2 (en) 2000-05-11 2008-03-04 Glycozym Aps Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
AU2003275952A1 (en) * 2002-11-08 2004-06-07 Glycozym Aps Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use
US7888048B2 (en) * 2004-06-21 2011-02-15 Exelixis, Inc. P4HAS as modifiers of the IGFR pathway and methods of use
CA2977261A1 (en) 2006-10-04 2008-04-10 Kobenhavns Universitet Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
WO2011024412A1 (en) * 2009-08-25 2011-03-03 Oncotherapy Science, Inc. Gene and polypeptide relating to breast cancer
WO2014024820A1 (ja) * 2012-08-06 2014-02-13 塩野義製薬株式会社 新規慢性腎臓病治療用医薬組成物及び新規慢性腎臓病治療薬のスクリーニング方法
GB201406767D0 (en) 2014-04-15 2014-05-28 Cancer Rec Tech Ltd Humanized anti-Tn-MUC1 antibodies anf their conjugates
US11058675B2 (en) 2018-03-29 2021-07-13 Carnegie Mellon University Cell-based screening and compounds that modulate GaINAc-transferases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
HUP0003418A2 (hu) * 1997-09-05 2001-02-28 Glycim Oy Szintetikus, kétértékű, sLex-tartalmú polilaktózaminok és eljárás előállításukra
MXPA00012237A (es) * 1998-06-10 2002-11-15 Glycodesign Inc Biblioteca de compuestos combinatorios derigidos y ensayos de alto rendimiento para seleccionar los mismos.

Also Published As

Publication number Publication date
WO2001085215A3 (en) 2002-06-27
ATE361375T1 (de) 2007-05-15
AU2001258234A1 (en) 2001-11-20
WO2001085215A9 (en) 2002-01-24
EP1282725A2 (de) 2003-02-12
WO2001085215A2 (en) 2001-11-15
EP1282725B1 (de) 2007-05-02

Similar Documents

Publication Publication Date Title
Vićovac et al. Galectin-1 and-3 in cells of the first trimester placental bed.
EA200601738A1 (ru) Модифицированные белки буганины, цитотоксины и способы их применения
ATE454447T1 (de) Peptidagonisten für prostata-spezifisches antigen und ihre verwendung
WO2000032631A3 (en) Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
DE60128218D1 (de) METHODEN ZUR MODELIERUNG DIE FUNKTION VON POLYPEPTID GalNAc TRANSFERASEN UND ZURSCREENING SUBSTANZEN DAFÜR
DE112006000677A5 (de) Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
CA2295936A1 (en) Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
WO2007073509A8 (en) Modified annexin proteins and methods for their use in organ transplantation
EP2343318A3 (de) Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden
WO2003066830A3 (en) Human monoclonal antibodies against membrane proteins
PL378566A1 (pl) Ligandy dla białek wiążących TGF-beta i ich zastosowania
ATE469981T1 (de) Tests auf proteinkinasen mit fluoreszierenden proteinsubstraten
WO2007039256A3 (de) Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
CN105744944A (zh) 免疫系统调节器
Datta et al. Increased phosphorylation of eukaryotic initiation factor 2α at the G2/M boundary in human osteosarcoma cells correlates with deglycosylation of p67 and a decreased rate of protein synthesis
WO2005123760A3 (en) Treating cancer
Shirshev et al. Hormonal regulation of NK cell cytotoxic activity
BR112022005426A2 (pt) Polipeptídeos de fusão dap10/dap12
AU2021278998A8 (en) Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC)
ATE355302T1 (de) N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation
WO2005069726A3 (en) Hybrid and chimeric polypeptides that regulate activation of complement
ATE352563T1 (de) Transplantatabstossung und damit verbundene zustände
DE69922489D1 (de) Rekombinantes aktives humänes zona pellucida protein 3 (hzp3)
Nakamura et al. Calreticulin is present in the acrosome of spermatids of rat testis
NO20013257L (no) Beinstimulerende faktor

Legal Events

Date Code Title Description
8332 No legal effect for de